Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

[11C]MTP-38 first use in human PET studies shows promise for neurological disorders

Aug. 20, 2021

China Pharmaceutical University targets WDR5/MLL1 interaction with DDO-2213

Aug. 12, 2021

KV-998083 effective in models of thrombosis and vascular leakage

July 30, 2021

Ghent University Hybrid CAR-T cell platform has dual anti-HIV effects

July 28, 2021

CFT-2718 shows promising tumor growth reduction in models of SCLC

July 23, 2021

Discovery of novel siderophore-monobactam conjugates against P. Aeruginosa

July 15, 2021

TP-03 enhances the stimulating effect of hCG on testicular steroidogenesis

July 14, 2021

VRG-101: a new PIKfyve inhibitor for SARS-CoV-2

July 14, 2021

Pentadefenin hydrogel developed for treating vaginitis

July 12, 2021

EDP-721, a novel HBV RNA destabilizer with promising preclinical efficacy

July 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.